Articles from BioResearch Compliance Report (July 1, 2007)

Title	Author	Type	Words
Adaptive clinical trial closes two months early, saves Wyeth $1.5 million.	Pickett, Joseph	Clinical report	610
Adoption slowed by media and congressional scrutiny regarding 'drug safety,' ex-deputy commissioner says.	Pickett, Joseph		580
BiMo inspection FOIA Log.		Brief article	252
Charous gets 483 for failing to follow investigational plan.	Charous, Bruce		460
Failure to report adverse events noted in 483 for Purdue Pharma.	Pickett, Joseph		156
IRB Determination Letters.			80
Merck outlines patterns of success for adaptive trials.			247
PPD Development hit with 2-item 483 for analytical run flaws.	Pickett, Joseph		433
Protocol development includes adaptive evaluation.	Pickett, Joseph		460
Warning letters.			673
Wyeth exec warns about 'drug safety' hampering clinical benefit; non-U.S. subjects now account for 70% of trials.	Pickett, Joseph		801